Quick Answer
BIOTRICITY INC. reported R&D Expense of $2.16 million for fiscal year 2025.
BIOTRICITY INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.16M | -16.2% |
| 2024 | $2.57M | -20.4% |
| 2023 | $3.23M | +17.7% |
| 2022 | $2.74M | +33.3% |
| 2021 | $2.06M | +51.0% |
| 2020 | $1.36M | +4.1% |
| 2019 | $1.31M | -25.7% |
| 2018 | $1.76M | +54.8% |
| 2017 | $1.14M | +4.5% |
| 2016 | $1.09M | -4.7% |
| 2015 | $1.14M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $623.6K | +13.1% | +3.4% |
| September 30, 2025 | $602.8K | +16.4% | -13.4% |
| June 30, 2025 | $696.2K | +35.5% | +26.3% |
| December 31, 2024 | $551.2K | +21.7% | +6.4% |
| September 30, 2024 | $518.0K | -25.8% | +0.8% |
| June 30, 2024 | $513.9K | -27.9% | +13.5% |
| December 31, 2023 | $453.0K | -48.3% | -35.1% |
| September 30, 2023 | $697.6K | -15.8% | -2.2% |
- BIOTRICITY INC. showed a decrease of -16.2% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, BIOTRICITY INC.’s r&d expense has grown by 88.5% (from $1.14 million to $2.16 million).
- The most recent figure is from BIOTRICITY INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: